• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

效应子 SseK3 的糖基转移酶活性的结构基础。

Structural basis for the glycosyltransferase activity of the effector SseK3.

机构信息

From the Molecular Structure of Cell Signalling Laboratory, Francis Crick Institute, 1 Midland Road, London NW1 1AT, United Kingdom.

the Section of Microbiology, Medical Research Council Centre for Molecular Bacteriology and Infection, Imperial College London, London SW7 2AZ, United Kingdom, and.

出版信息

J Biol Chem. 2018 Apr 6;293(14):5064-5078. doi: 10.1074/jbc.RA118.001796. Epub 2018 Feb 15.

DOI:10.1074/jbc.RA118.001796
PMID:29449376
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5892559/
Abstract

The -secreted effector SseK3 translocates into host cells, targeting innate immune responses, including NF-κB activation. SseK3 is a glycosyltransferase that transfers an -acetylglucosamine (GlcNAc) moiety onto the guanidino group of a target arginine, modulating host cell function. However, a lack of structural information has precluded elucidation of the molecular mechanisms in arginine and GlcNAc selection. We report here the crystal structure of SseK3 in its apo form and in complex with hydrolyzed UDP-GlcNAc. SseK3 possesses the typical glycosyltransferase type-A (GT-A)-family fold and the metal-coordinating DD motif essential for ligand binding and enzymatic activity. Several conserved residues were essential for arginine GlcNAcylation and SseK3-mediated inhibition of NF-κB activation. Isothermal titration calorimetry revealed SseK3's preference for manganese coordination. The pattern of interactions in the substrate-bound SseK3 structure explained the selection of the primary ligand. Structural rearrangement of the C-terminal residues upon ligand binding was crucial for SseK3's catalytic activity, and NMR analysis indicated that SseK3 has limited UDP-GlcNAc hydrolysis activity. The release of free -acetyl α-d-glucosamine, and the presence of the same molecule in the SseK3 active site, classified it as a retaining glycosyltransferase. A glutamate residue in the active site suggested a double-inversion mechanism for the arginine -glycosylation reaction. Homology models of SseK1, SseK2, and the orthologue NleB1 reveal differences in the surface electrostatic charge distribution, possibly accounting for their diverse activities. This first structure of a retaining GT-A arginine -glycosyltransferase provides an important step toward a better understanding of this enzyme class and their roles as bacterial effectors.

摘要

分泌效应子 SseK3 易位进入宿主细胞,靶向先天免疫反应,包括 NF-κB 激活。SseK3 是一种糖基转移酶,它将一个 N-乙酰葡萄糖胺(GlcNAc)部分转移到靶精氨酸的胍基上,调节宿主细胞功能。然而,由于缺乏结构信息,阻碍了对精氨酸和 GlcNAc 选择的分子机制的阐明。我们在此报告 SseK3 在其无配体形式和与水解 UDP-GlcNAc 复合物的晶体结构。SseK3 具有典型的糖基转移酶 A 型(GT-A)家族折叠和金属配位 DD 基序,这对于配体结合和酶活性是必不可少的。几个保守残基对于精氨酸 GlcNAc 化和 SseK3 介导的 NF-κB 激活抑制是必不可少的。等温滴定量热法显示 SseK3 优先配位锰。结合底物的 SseK3 结构中的相互作用模式解释了主要配体的选择。配体结合时 C 末端残基的结构重排对于 SseK3 的催化活性至关重要,NMR 分析表明 SseK3 具有有限的 UDP-GlcNAc 水解活性。游离 N-乙酰 α-d-葡萄糖胺的释放以及相同分子在 SseK3 活性部位的存在将其归类为保留型糖基转移酶。活性部位的一个谷氨酸残基表明精氨酸糖基化反应的双反转机制。SseK1、SseK2 和同源物 NleB1 的同源模型揭示了表面静电电荷分布的差异,这可能解释了它们不同的活性。第一个保留型 GT-A 精氨酸糖基转移酶的结构为更好地理解该酶类及其作为细菌效应子的作用提供了重要的一步。

相似文献

1
Structural basis for the glycosyltransferase activity of the effector SseK3.效应子 SseK3 的糖基转移酶活性的结构基础。
J Biol Chem. 2018 Apr 6;293(14):5064-5078. doi: 10.1074/jbc.RA118.001796. Epub 2018 Feb 15.
2
Catalytic DxD motif caged in Asx-turn and Met-aromatic interaction attenuates the pathogenic glycosylation of SseK2/NleB2 effectors.催化 DxD 基序被 Asx 环和 Met 芳环相互作用所限制,从而减弱了 SseK2/NleB2 效应物的致病糖基化。
Sci Rep. 2022 Nov 11;12(1):19288. doi: 10.1038/s41598-022-22803-y.
3
Effectors SseK1 and SseK3 Target Death Domain Proteins in the TNF and TRAIL Signaling Pathways.效应子 SseK1 和 SseK3 靶向 TNF 和 TRAIL 信号通路中的死亡结构域蛋白。
Mol Cell Proteomics. 2019 Jun;18(6):1138-1156. doi: 10.1074/mcp.RA118.001093. Epub 2019 Mar 22.
4
SseK1 and SseK3 Type III Secretion System Effectors Inhibit NF-κB Signaling and Necroptotic Cell Death in Salmonella-Infected Macrophages.SseK1和SseK3 III型分泌系统效应蛋白抑制沙门氏菌感染巨噬细胞中的NF-κB信号传导和坏死性细胞死亡。
Infect Immun. 2017 Feb 23;85(3). doi: 10.1128/IAI.00010-17. Print 2017 Mar.
5
NleB/SseK effectors from , , and display distinct differences in host substrate specificity.来自、和的NleB/SseK效应蛋白在宿主底物特异性方面表现出明显差异。
J Biol Chem. 2017 Jul 7;292(27):11423-11430. doi: 10.1074/jbc.M117.790675. Epub 2017 May 18.
6
SseK3 Is a Salmonella Effector That Binds TRIM32 and Modulates the Host's NF-κB Signalling Activity.SseK3是一种沙门氏菌效应蛋白,它能结合TRIM32并调节宿主的NF-κB信号传导活性。
PLoS One. 2015 Sep 22;10(9):e0138529. doi: 10.1371/journal.pone.0138529. eCollection 2015.
7
Type III Secretion Effectors with Arginine N-Glycosyltransferase Activity.具有精氨酸N-糖基转移酶活性的III型分泌效应蛋白。
Microorganisms. 2020 Mar 2;8(3):357. doi: 10.3390/microorganisms8030357.
8
Structural insights showing how arginine is able to be glycosylated by pathogenic effector proteins.结构见解表明精氨酸如何能够被致病效应蛋白进行糖基化。
BMB Rep. 2018 Dec;51(12):609-610. doi: 10.5483/BMBRep.2018.51.12.269.
9
Arginine GlcNAcylation of Rab small GTPases by the pathogen Salmonella Typhimurium.沙门氏菌属 Typhimurium 对 Rab 小分子 GTPases 的精氨酸 GlcNAc 酰化作用。
Commun Biol. 2020 Jun 5;3(1):287. doi: 10.1038/s42003-020-1005-2.
10
Structural basis for arginine glycosylation of host substrates by bacterial effector proteins.细菌效应蛋白对宿主底物精氨酸糖基化的结构基础。
Nat Commun. 2018 Oct 16;9(1):4283. doi: 10.1038/s41467-018-06680-6.

引用本文的文献

1
Modulation of host Rab GTPases by Salmonella: mechanisms of immune evasion and intracellular replication.沙门氏菌对宿主Rab GTP酶的调控:免疫逃避和细胞内复制机制
Mol Biol Rep. 2025 Apr 30;52(1):440. doi: 10.1007/s11033-025-10547-7.
2
STD NMR Epitope Perturbation by Mutation Unveils the Mechanism of YM155 as an Arginine-Glycosyltransferases Inhibitor Effective in Treating Enteropathogenic Diseases.通过突变进行的STD NMR表位扰动揭示了YM155作为一种对治疗肠道致病性疾病有效的精氨酸糖基转移酶抑制剂的作用机制。
JACS Au. 2025 Mar 5;5(3):1279-1288. doi: 10.1021/jacsau.4c01140. eCollection 2025 Mar 24.
3
A pan-genome perspective on the evolutionary dynamics of polyphyly, virulence, and antibiotic resistance in serovar Mbandaka highlights emerging threats to public health and food safety posed by cloud gene families.

本文引用的文献

1
Structural Basis for EarP-Mediated Arginine Glycosylation of Translation Elongation Factor EF-P.耳 P 介导的延伸因子 EF-P 精氨酸糖基化的结构基础。
mBio. 2017 Sep 26;8(5):e01412-17. doi: 10.1128/mBio.01412-17.
2
The bacterial arginine glycosyltransferase effector NleB preferentially modifies Fas-associated death domain protein (FADD).细菌精氨酸糖基转移酶效应蛋白NleB优先修饰Fas相关死亡结构域蛋白(FADD)。
J Biol Chem. 2017 Oct 20;292(42):17337-17350. doi: 10.1074/jbc.M117.805036. Epub 2017 Aug 31.
3
Salmonella SPI-2 Type III Secretion System Effectors: Molecular Mechanisms And Physiological Consequences.
从泛基因组角度看血清型姆班达卡菌的多系性、毒力及抗生素抗性的进化动态,凸显了云基因家族对公共卫生和食品安全构成的新威胁。
Curr Res Food Sci. 2024 Dec 13;10:100957. doi: 10.1016/j.crfs.2024.100957. eCollection 2025.
4
Experimental phasing opportunities for macromolecular crystallography at very long wavelengths.极长波长下大分子晶体学的实验相位测定机会。
Commun Chem. 2023 Oct 12;6(1):219. doi: 10.1038/s42004-023-01014-0.
5
Preference of Bacterial Rhamnosyltransferases for 6-Deoxysugars Reveals a Strategy To Deplete O-Antigens.细菌鼠李糖基转移酶对 6-去氧糖的偏好揭示了一种耗尽 O-抗原的策略。
J Am Chem Soc. 2023 Jul 26;145(29):15639-15646. doi: 10.1021/jacs.3c03005. Epub 2023 Jul 12.
6
Speaking the host language: how effector proteins manipulate the host.讲宿主语言:效应蛋白如何操纵宿主。
Microbiology (Reading). 2023 Jun;169(6). doi: 10.1099/mic.0.001342.
7
Catalytic DxD motif caged in Asx-turn and Met-aromatic interaction attenuates the pathogenic glycosylation of SseK2/NleB2 effectors.催化 DxD 基序被 Asx 环和 Met 芳环相互作用所限制,从而减弱了 SseK2/NleB2 效应物的致病糖基化。
Sci Rep. 2022 Nov 11;12(1):19288. doi: 10.1038/s41598-022-22803-y.
8
Arginine glycosylation regulates UDP-GlcNAc biosynthesis in Salmonella enterica.精氨酸糖基化调节沙门氏菌中 UDP-GlcNAc 的生物合成。
Sci Rep. 2022 Mar 28;12(1):5293. doi: 10.1038/s41598-022-09276-9.
9
Arginine GlcNAcylation and Activity Regulation of PhoP by a Type III Secretion System Effector in .III型分泌系统效应蛋白对PhoP的精氨酸N-乙酰葡糖胺化及活性调控 于……中
Front Microbiol. 2022 Jan 20;12:825743. doi: 10.3389/fmicb.2021.825743. eCollection 2021.
10
NleB/SseK-catalyzed arginine-glycosylation and enteropathogen virulence are finely tuned by a single variable position contiguous to the catalytic machinery.NleB/SseK催化的精氨酸糖基化和肠道病原体毒力由与催化机制相邻的单个可变位置精细调节。
Chem Sci. 2021 Aug 19;12(36):12181-12191. doi: 10.1039/d1sc04065k. eCollection 2021 Sep 22.
沙门氏菌 SPI-2 型 III 型分泌系统效应器:分子机制和生理后果。
Cell Host Microbe. 2017 Aug 9;22(2):217-231. doi: 10.1016/j.chom.2017.07.009.
4
NleB/SseK effectors from , , and display distinct differences in host substrate specificity.来自、和的NleB/SseK效应蛋白在宿主底物特异性方面表现出明显差异。
J Biol Chem. 2017 Jul 7;292(27):11423-11430. doi: 10.1074/jbc.M117.790675. Epub 2017 May 18.
5
SseK1 and SseK3 Type III Secretion System Effectors Inhibit NF-κB Signaling and Necroptotic Cell Death in Salmonella-Infected Macrophages.SseK1和SseK3 III型分泌系统效应蛋白抑制沙门氏菌感染巨噬细胞中的NF-κB信号传导和坏死性细胞死亡。
Infect Immun. 2017 Feb 23;85(3). doi: 10.1128/IAI.00010-17. Print 2017 Mar.
6
The conformational plasticity of glycosyltransferases.糖基转移酶的构象可塑性。
Curr Opin Struct Biol. 2016 Oct;40:23-32. doi: 10.1016/j.sbi.2016.07.007. Epub 2016 Jul 21.
7
In-vacuum long-wavelength macromolecular crystallography.真空内长波长大分子晶体学
Acta Crystallogr D Struct Biol. 2016 Mar;72(Pt 3):430-9. doi: 10.1107/S2059798316001078. Epub 2016 Mar 1.
8
Mutagenesis and Functional Analysis of the Bacterial Arginine Glycosyltransferase Effector NleB1 from Enteropathogenic Escherichia coli.致病性大肠杆菌中细菌精氨酸糖基转移酶效应蛋白NleB1的诱变与功能分析
Infect Immun. 2016 Apr 22;84(5):1346-1360. doi: 10.1128/IAI.01523-15. Print 2016 May.
9
The reaction mechanism of retaining glycosyltransferases.保留型糖基转移酶的反应机制。
Biochem Soc Trans. 2016 Feb;44(1):51-60. doi: 10.1042/BST20150177.
10
Bacterial glycosyltransferase toxins.细菌糖基转移酶毒素
Cell Microbiol. 2015 Dec;17(12):1752-65. doi: 10.1111/cmi.12533. Epub 2015 Nov 4.